Phase 1
- Phase IA Phase 1 Study of ASP3082 in Participants With Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies With KRAS G12D MutationPrincipal Investigator: Patricia LoRusso
- Phase IA Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy in Participants With Selected Advanced Solid TumorsPrincipal Investigator: Patricia LoRusso